The efficacy of induction chemoradiotherapy followed by surgery in stage IIIA-proven N2 NSCLC and the influence of lymph node downstage on the incidence of postoperative recurrence
A. Tateishi (Kamogawaam, Japan), M. Misawa (Kamogawa, Japan), H. Nomori (Kamogawa, Japan), M. Nemoto (Kamogawa, Japan), R. Tsuzuki (Kamogawa, Japan), A. Otsuki (Kamogawa, Japan), K. Nakashima (Kamogawa, Japan), Y. Oyama (Kamogawa, Japan), H. Sugimura (Kamogawa, Japan), K. Shoji (Kamogawa, Japan), M. Aoshima (Kamogawa, Japan)
Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2222
Disease area: Thoracic oncology
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tateishi (Kamogawaam, Japan), M. Misawa (Kamogawa, Japan), H. Nomori (Kamogawa, Japan), M. Nemoto (Kamogawa, Japan), R. Tsuzuki (Kamogawa, Japan), A. Otsuki (Kamogawa, Japan), K. Nakashima (Kamogawa, Japan), Y. Oyama (Kamogawa, Japan), H. Sugimura (Kamogawa, Japan), K. Shoji (Kamogawa, Japan), M. Aoshima (Kamogawa, Japan). The efficacy of induction chemoradiotherapy followed by surgery in stage IIIA-proven N2 NSCLC and the influence of lymph node downstage on the incidence of postoperative recurrence. 2222
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: